Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoto Sassa

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentationMasashi Kato, Toyonori Tsuzuki, Kyosuke Kimura, et al.
The Prostate|November 3, 2017
Prognostic parameter for high risk prostate cancer patients at initial presentationMasashi Kato, Kyosuke Kimura, Akihiro Hirakawa, et al.
Virchows Archiv : an International Journal of Pathology|January 9, 2021
pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients' prognostic accuracyTomoyasu Sano, Masashi Kato, Naoto Sassa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 4, 2025
[Safety and Efficacy of Transcatheter Arterial Embolization for Renal Angiomyolipoma in Aichi Medical University Hospital]Ako Shirai, Keishi Kajikawa, Shoichi Sato, et al.
International Journal of Clinical Oncology|July 22, 2021
Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinomaMotohide Uemura, Noboru Nakaigawa, Naoto Sassa, et al.
International Journal of Clinical Oncology|January 3, 2023
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinomaNoboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 6, 2023
Impact of the coronavirus disease 2019 pandemic on the number of undergoing radical nephroureterectomy and postoperative adjuvant systematic therapy for upper tract urothelial carcinomas in Japan: A multicenter retrospective studyKatsuhisa Tsuruta, Tsuyoshi Majima, Toshinori Nishikimi, et al.
Nagoya Journal of Medical Science|December 29, 2023
Creation of synthetic contrast-enhanced computed tomography images using deep neural networks to screen for renal cell carcinomaNaoto Sassa, Yoshitaka Kameya, Tomoichi Takahashi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 21, 2020
[PRIMARY PROSTATIC RHABDOMYOSARCOMA WITH REPEATING CEREBRAL HEMORRHAGE FROM BRAIN METASTASES IN AN ADULT: A CASE REPORT]Kosuke Tochigi, Naoto Sassa, Yoshie Kanada, et al.
Anticancer Research|July 5, 2022
Impact of Histological Variants on Clinical Responses to Pembrolizumab in Patients With Metastatic Urothelial CancerSatoshi Inoue, Naoto Sassa, Hideji Kawanishi, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentationMasashi Kato, Toyonori Tsuzuki, Kyosuke Kimura, et al.
The Prostate|November 3, 2017
Prognostic parameter for high risk prostate cancer patients at initial presentationMasashi Kato, Kyosuke Kimura, Akihiro Hirakawa, et al.
Virchows Archiv : an International Journal of Pathology|January 9, 2021
pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients' prognostic accuracyTomoyasu Sano, Masashi Kato, Naoto Sassa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 4, 2025
[Safety and Efficacy of Transcatheter Arterial Embolization for Renal Angiomyolipoma in Aichi Medical University Hospital]Ako Shirai, Keishi Kajikawa, Shoichi Sato, et al.
International Journal of Clinical Oncology|July 22, 2021
Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinomaMotohide Uemura, Noboru Nakaigawa, Naoto Sassa, et al.
International Journal of Clinical Oncology|January 3, 2023
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinomaNoboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 6, 2023
Impact of the coronavirus disease 2019 pandemic on the number of undergoing radical nephroureterectomy and postoperative adjuvant systematic therapy for upper tract urothelial carcinomas in Japan: A multicenter retrospective studyKatsuhisa Tsuruta, Tsuyoshi Majima, Toshinori Nishikimi, et al.
Nagoya Journal of Medical Science|December 29, 2023
Creation of synthetic contrast-enhanced computed tomography images using deep neural networks to screen for renal cell carcinomaNaoto Sassa, Yoshitaka Kameya, Tomoichi Takahashi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 21, 2020
[PRIMARY PROSTATIC RHABDOMYOSARCOMA WITH REPEATING CEREBRAL HEMORRHAGE FROM BRAIN METASTASES IN AN ADULT: A CASE REPORT]Kosuke Tochigi, Naoto Sassa, Yoshie Kanada, et al.
Anticancer Research|July 5, 2022
Impact of Histological Variants on Clinical Responses to Pembrolizumab in Patients With Metastatic Urothelial CancerSatoshi Inoue, Naoto Sassa, Hideji Kawanishi, et al.
Pageof 9